PUBLISHER: Grand View Research | PRODUCT CODE: 2067477
PUBLISHER: Grand View Research | PRODUCT CODE: 2067477
The global multiplex PCR panel testing market size was estimated at USD 2.58 billion in 2025 and is projected to reach USD 4.86 billion by 2033, registering a CAGR of 8.42% from 2026 to 2033. The market growth is driven by the growing prevalence of respiratory and gastrointestinal infections and strong demand for rapid syndromic testing in infectious disease diagnostics.
Moreover, advancements in multiplexing technologies, laboratory automation, and high-throughput molecular workflows are supporting broader adoption of multiplex PCR panels across healthcare settings. Expanding utilization of decentralized and point-of-care molecular diagnostic platforms is further contributing to market growth.
The rising prevalence of respiratory and gastrointestinal infections is driving market growth due to growing demand for rapid and accurate pathogen identification. Multiplex PCR panel enables simultaneous detection of multiple viral, bacterial, and parasitic pathogens from a single sample, making them well-suited for managing infections associated with overlapping clinical symptoms. The growing incidence of respiratory infections, including influenza, RSV, pneumonia, and other lower respiratory tract infections, along with outbreaks of gastrointestinal infections such as norovirus and Shigella, is accelerating the adoption of syndromic molecular diagnostics across hospitals and clinical laboratories. According to a study published in The Lancet in September 2024, Global Burden of Disease analyses estimated that lower respiratory infections accounted for approximately 344 million cases globally and continued to rank among the leading infectious causes of mortality worldwide. Moreover, the Centers for Disease Control and Prevention reported in April 2026 that nearly 2,500 norovirus outbreaks occur annually in the U.S., while norovirus continues to cause approximately 685 million cases of acute gastroenteritis globally each year.
The growing demand for rapid syndromic testing in infectious disease diagnostics is supporting market growth due to the need for faster and more comprehensive pathogen detection. Syndromic multiplex PCR panel enables simultaneous identification of multiple pathogens associated with similar clinical symptoms from a single patient sample, reducing diagnostic turnaround time compared with conventional culture-based and single-target testing methods. Healthcare providers are adopting rapid syndromic testing to improve early diagnosis, patient triage, infection control, and treatment selection, particularly in respiratory, gastrointestinal, bloodstream, and central nervous system infections. The growing clinical emphasis on antimicrobial stewardship and reduction of unnecessary antibiotic use is further supporting the adoption of multiplex syndromic molecular diagnostics across hospitals, emergency departments, and clinical laboratories.
Continuous advancements in multiplexing and laboratory automation technologies are driving market growth by improving testing efficiency, workflow automation, and diagnostic accuracy. Innovations in high-plex assay development, automated sample preparation, integrated molecular systems, and real-time data analysis are enabling simultaneous detection of multiple pathogens with faster turnaround times and minimal hands-on time. These technologies also support higher laboratory throughput and improved operational efficiency in clinical settings. For instance, in January 2026, Cepheid received U.S. FDA clearance for the Xpert GI Panel, a multiplex PCR assay designed for simultaneous detection of 11 gastrointestinal bacterial, viral, and parasitic pathogens from a single stool sample. The panel utilizes Cepheid's 10-color multiplexing technology on GeneXpert systems, supporting rapid syndromic testing and automated molecular diagnostic workflows.
Global Multiplex PCR Panel Testing Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global multiplex PCR panel testing market report based on disease application, end use, throughput, testing setting, and region: